iifl-logo

Glenmark Pharmaceuticals Ltd Historical Data

Add as a Preferred Source on Google
₹2,293
(4.60%)
Oct 9, 2026|03:54:41 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Historical Data

11/09/2026calendar-icon
11/10/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

09-Sep-2026

2,486.9

2,486.92,400.12,43534,8911,03,21,44,201.11,59,072

10-Sep-2026

2,445.9

2,449.92,403.12,41525,79263,48,89,477.21,51,319

11-Sep-2026

2,411.2

2,431.92,384.12,419.234,93983,71,67,783.51,54,001

15-Sep-2026

2,420.8

2,429.82,346.62,371.730,41865,74,83,3231,41,296

16-Sep-2026

2,371.7

2,425.82,306.32,41043,7371,60,38,65,678.33,13,621

17-Sep-2026

2,406.8

2,416.92,388.42,41619,96454,63,34,330.41,01,278

18-Sep-2026

2,409.8

2,447.42,396.82,447.427,9021,32,00,67,761.93,62,810

21-Sep-2026

2,425

2,473.62,4242,45028,37899,66,53,297.42,09,679

22-Sep-2026

2,460.4

2,4722,4432,461.432,18999,07,23,013.72,36,757

23-Sep-2026

2,472

2,482.62,453.62,47537,7041,47,65,66,465.24,01,194

24-Sep-2026

2,460

2,4702,4222,430.429,6691,10,89,29,756.12,44,668

25-Sep-2026

2,425

2,435.22,365.72,38061,4161,87,62,63,270.54,50,492

28-Sep-2026

2,380

2,392.52,307.32,325.760,5672,31,05,15,355.85,28,698

29-Sep-2026

2,330.4

2,441.52,2922,441.556,8083,00,70,93,026.98,39,781

30-Sep-2026

2,391

2,4102,334.72,334.760,7102,99,96,14,989.87,12,031

01-Oct-2026

2,339

2,3602,279.32,33156,1852,26,09,56,708.36,55,232

05-Oct-2026

2,325

2,340.52,273.52,29543,7341,12,57,85,455.32,45,450

06-Oct-2026

2,312.2

2,3202,277.32,31140,0351,13,33,30,062.12,77,080

07-Oct-2026

2,314.9

2,326.82,274.42,282.332,7351,14,46,24,620.82,53,725

08-Oct-2026

2,280

2,2842,181.22,192.240,0681,81,28,09,010.24,96,354

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.